UBS Group
PILL icon

UBS Group’s Direxion Daily Pharmaceutical & Medical Bull 3X ETF PILL Stock Holding History

UBS Group’s Portfolio PILL Stock Details PILL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.4K Sell
1,018
-207
-17% -$2.65K ﹤0.01% 8207
2026
Q1 		$12.5K Buy
+1,225
New +$14.4K ﹤0.01% 8249
2025
Q4 		– Sell
-3,412
Closed -$27.5K – 11012
2025
Q3 		$27.5K Sell
3,412
-7,871
-70% -$53.4K ﹤0.01% 7952
2025
Q2 		$58.3K Buy
11,283
+10,280
+1,025% +$53.3K ﹤0.01% 7653
2025
Q1 		$7.24K Buy
+1,003
New +$7.51K ﹤0.01% 8843
2024
Q3 		– Sell
-7,533
Closed -$46.9K – 9928
2024
Q2 		$46.9K Buy
7,533
+6,668
+771% +$44.4K ﹤0.01% 6738
2024
Q1 		$7.11K Buy
+865
New +$7.24K ﹤0.01% 7411
2023
Q1 		– Sell
-549
Closed -$4.92K – 10189
2022
Q4 		$4.92K Sell
549
-3,179
-85% -$30.6K ﹤0.01% 9247
2022
Q3 		$33K Buy
3,728
+3,385
+987% +$37.5K ﹤0.01% 6768
2022
Q2 		$4K Buy
+343
New +$3.84K ﹤0.01% 9101

Other funds holding PILL

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
FC
Financial Consulate Hunt Valley, Maryland $899M AUM 20.23% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group's PILL Position: Q2 2026 in Review

UBS Group reduced its Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) stake by 17% in Q2 2026, selling an estimated $2.65K and leaving 1,018 shares worth $18.4K. The position accounts for ﹤0.01% of the portfolio, ranked #8207.

UBS Group first reported a position in PILL in Q2 2022 and has held it in 10 quarters since. The position peaked at $58.3K in Q2 2025. 7 funds tracked by Wall St. Rank hold PILL as of Q2 2026.

  • UBS Group held 1,018 shares of Direxion Daily Pharmaceutical & Medical Bull 3X ETF worth $18.4K as of Q2 2026.
  • UBS Group sold 207 Direxion Daily Pharmaceutical & Medical Bull 3X ETF shares in Q2 2026, an estimated $2.65K.
  • Direxion Daily Pharmaceutical & Medical Bull 3X ETF made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8207 holding.
  • UBS Group first reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in Q2 2022 and has held it in 10 quarters since.
  • UBS Group's Direxion Daily Pharmaceutical & Medical Bull 3X ETF position peaked at $58.3K in Q2 2025.
  • 7 funds tracked by Wall St. Rank held Direxion Daily Pharmaceutical & Medical Bull 3X ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.